Back to Directory
Cenegermin
Cognitive EnhancementRecombinant NGF eye drops for neurotrophic keratitis, FDA-approved ophthalmic peptide.
Key Benefits
- ✓Treats neurotrophic keratitis
- ✓Promotes corneal healing
- ✓Nerve regeneration in eye
- ✓First topical NGF therapy
Dosing Information
Dosage Range
20 mcg/ml (1 drop)
Frequency
Six times daily
Typical Duration
8 weeks
Detailed Protocol
Applied as eye drops in affected eye(s) six times daily. Continue for 8 weeks or until healing. Must be kept refrigerated. Prescription only.
About Cenegermin
Cenegermin (Oxervate) is recombinant human nerve growth factor (NGF) formulated as eye drops for neurotrophic keratitis, a rare degenerative corneal disease. First FDA-approved topical biological treatment for ocular surface disease.
Research Notes
FDA-approved in 2018 for neurotrophic keratitis. First approved NGF therapy. Significant advance for rare corneal disease. Very expensive treatment.
Potential Side Effects
- •Eye pain
- •Ocular hyperemia
- •Eye inflammation
- •Headache
- •Expensive
Always consult with a healthcare professional before starting any peptide therapy.